August 30, 2014
Article
Clinical Articles
Recent advances in immunotherapy and in agents that target specific genetic mutations in the mitogen-activated protein kinase (MAPK) pathway have led to dramatic improvements in outcomes for patients with advanced cutaneous melanoma.
August 28, 2014
Article
Clinical Articles
Risk factors for contracting melanoma are complex and can include environmental exposure and an individual’s genetic susceptibility, but people at highest risk are those with a personal or family history of melanoma and those with large, atypical, and/or multiple (more than 50) nevi.
May 07, 2014
Article
Clinical Articles
Many patients with melanoma are diagnosed with unresectable stage III or IV disease that requires systemic treatment. Treatment of melanoma depends largely on the stage at diagnosis.
May 07, 2014
Article
Clinical Articles
This article provides an overview of clinical trials in melanoma.